13F filer · CIK 1037792 ↗
Paradigm Capital Management Inc
You are looking at Q3 2025. See the latest, Q2 2026 →
Reported value
$2.31B
+12% on the quarter before
Positions
126
9 new · 5 sold out
Top 10
56.9%
of the value
Est. gain
+$296.8M
on stocks held all quarter
Est. return
+15.5%
on those stocks since Q2 2025
Positions as of Sep 30, 2025, from Paradigm Capital Management Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2025. Striped tiles are options.
Largest buys
Since Q2 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Penguin Solutions Inc~$18.8MNew · 0.0% → 0.8%+716,051 shares
- Dentsply Sirona, Inc.~$12.0MNew · 0.0% → 0.5%+942,251 shares
- Pennant Group Inc.~$11.9MAdded · 1.4% → 1.6%+473,800 shares
- Masterbrand Inc.~$7.6MNew · 0.0% → 0.3%+580,000 shares
- Angiodynamics, Inc.~$7.6MNew · 0.0% → 0.3%+678,200 shares
- Xerox Corp~$6.3MAdded · 0.5% → 0.6%+1,680,952 shares
- Quidel Corp~$5.7MAdded · 1.0% → 1.2%+193,212 shares
- Integra Lifesciences Holdings Corp~$5.0MAdded · 1.3% → 1.6%+348,300 shares
- Pacs Group, Inc.~$4.6MAdded · 0.1% → 0.3%+332,200 shares
- Owens And Minor, Inc.~$3.0MAdded · 0.9% → 0.5%+632,900 shares
Largest sells
Since Q2 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Penguin Solutions Inc~$22.8MSold out · 1.1% → 0.0%−1,153,100 shares
- Ducommun Inc~$21.8MCut · 4.0% → 3.2%−227,000 shares
- Modine~$19.5MCut · 7.8% → 9.2%−137,200 shares
- Calix Inc~$17.9MCut · 2.5% → 1.8%−291,800 shares
- Mimedx~$12.6MCut · 1.3% → 0.8%−1,801,196 shares
- Enviri Corp~$8.0MCut · 1.9% → 2.1%−629,900 shares
- Cerence~$6.5MCut · 1.3% → 1.1%−517,719 shares
- Nature`S Sunshine Products, Inc.~$5.7MSold out · 0.3% → 0.0%−384,162 shares
- Emcor~$5.2MCut · 0.8% → 0.7%−8,000 shares
- Kratos Defense~$4.4MCut · 0.6% → 0.9%−47,800 shares
Holdings
As of Sep 30, 2025. Changes are in shares against Jun 30, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BroadcomCOM · shares 0% · price +19.7% | 11.6% | $266.9M | +$43.9M | ||||||||
| ModineCOM · shares −8.4% · price +44.3% | 9.2% | $212.7M | +$65.3M | ||||||||
| FabrinetCOM · shares −0.2% · price +23.7% | 8.4% | $193.4M | +$37.1M | ||||||||
| Onto InnovationCOM · shares 0% · price +28.0% | 6.2% | $143.8M | +$31.5M | ||||||||
| JabilCOM · shares 0% · price −0.4% | 5.3% | $121.2M | −$518,847 | ||||||||
| Extreme NetworksCOM · shares −1.0% · price +15.0% | 4.4% | $101.9M | +$13.3M | ||||||||
| Ducommun IncCOM · shares −23% · price +16.3% | 3.2% | $74.1M | +$10.4M | ||||||||
| Veeco InstrumentsCOM · shares −2.1% · price +49.8% | 3.1% | $71.8M | +$23.9M | ||||||||
| Insight EnterprisesCOM · shares +0.6% · price −17.9% | 2.9% | $67.7M | −$14.6M | ||||||||
| Ensign Group, Inc.COM · shares 0% · price +12.0% | 2.6% | $59.5M | +$6.4M | ||||||||
| Globus MedicalCOM · shares +0.5% · price −3.0% | 2.4% | $54.2M | −$1.6M | ||||||||
| EnersysCOM · shares −2.1% · price +31.7% | 2.3% | $52.6M | +$12.7M | ||||||||
| Orthofix Medical Inc.COM · shares +0.1% · price +31.3% | 2.1% | $49.0M | +$11.7M | ||||||||
| EntegrisCOM · shares −2.8% · price +14.6% | 2.1% | $48.8M | +$6.2M | ||||||||
| Enviri CorpCOM · shares −14% · price +46.2% | 2.1% | $48.1M | +$15.2M | ||||||||
| Calix IncCOM · shares −30% · price +15.4% | 1.8% | $41.3M | +$5.5M | ||||||||
| Enovis CorporationCOM · shares +8.2% · price −3.3% | 1.6% | $36.6M | −$1.1M | ||||||||
| Integra Lifesciences Holdings CorpCOM · shares +16% · price +16.8% | 1.6% | $36.3M | +$4.5M | ||||||||
| Pennant Group Inc.COM · shares +50% · price −15.5% | 1.6% | $35.9M | −$4.4M | ||||||||
| Ribbon Communications IncCOM · shares +0.01% · price −5.2% | 1.4% | $33.2M | −$1.8M | ||||||||
| Concentrix CorpCOM · shares −13% · price −12.7% | 1.2% | $28.5M | −$4.1M | ||||||||
| Quidel CorpCOM · shares +26% · price +2.2% | 1.2% | $27.7M | +$470,163 | ||||||||
| CerenceCOM · shares −20% · price +22.0% | 1.1% | $25.4M | +$4.6M | ||||||||
| Tactile Systems TechnologyCOM · shares −5.0% · price +36.5% | 0.92% | $21.3M | +$5.7M | ||||||||
| Kratos DefenseCOM · shares −18% · price +96.7% | 0.85% | $19.7M | +$9.7M | ||||||||
| Total · 126 positions | 100% | $2.31B | +$296.8M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2025 to Q3 2025: 117 stocks held throughout, up $296.8M (+15.5%).
- Modine+$65.3M+44%
- Broadcom+$43.9M+20%
- Fabrinet+$37.1M+24%
- Onto Innovation+$31.5M+28%
- Veeco Instruments+$23.9M+50%
- Xerox Corp−$2.7M−29%
- Concentrix Corp−$4.1M−13%
- Pennant Group Inc.−$4.4M−16%
- Owens And Minor, Inc.−$8.5M−47%
- Insight Enterprises−$14.6M−18%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $3.67B+41% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $2.61B+10% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $2.38B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.31B+12% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.05B+14% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.80B−17% | SEC ↗ |
| Q4 2024 | Feb 18, 2025 | $2.16B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.25B+3% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.19B+5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.09B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.92B+10% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.74B−0% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.75B+16% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $1.51B−0% | SEC ↗ |
| Q4 2022 | Feb 3, 2023 | $1.51B+9% | SEC ↗ |
| Q3 2022 | Oct 26, 2022 | $1.39B−6% | SEC ↗ |
| Q2 2022 | Aug 2, 2022 | $1.47B−20% | SEC ↗ |
| Q1 2022 | May 25, 2022 | $1.85B−17% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $2.24B+15% | SEC ↗ |
| Q3 2021 | Nov 8, 2021 | $1.94B−7% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $2.08B+8% | SEC ↗ |
| Q1 2021 | May 5, 2021 | $1.93B+15% | SEC ↗ |
| Q4 2020 | Jan 20, 2021 | $1.67B+41% | SEC ↗ |
| Q3 2020 | Oct 20, 2020 | $1.19B+9% | SEC ↗ |
| Q2 2020 | Aug 3, 2020 | $1.09B+32% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $827.9M−36% | SEC ↗ |
| Q4 2019 | Feb 5, 2020 | $1.30B+16% | SEC ↗ |
| Q3 2019 | Nov 7, 2019 | $1.12B+2% | SEC ↗ |
| Q2 2019 | Aug 8, 2019 | $1.10B−4% | SEC ↗ |
| Q1 2019 | May 10, 2019 | $1.14B+12% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.02B−20% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $1.27B+3% | SEC ↗ |
| Q2 2018 | Aug 8, 2018 | $1.24B+5% | SEC ↗ |
| Q1 2018 | Apr 9, 2018 | $1.18B+1% | SEC ↗ |
| Q4 2017 | Feb 7, 2018 | $1.17B+2% | SEC ↗ |
| Q3 2017 | Nov 6, 2017 | $1.15B+4% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.11B+5% | SEC ↗ |
| Q1 2017 | May 9, 2017 | $1.06B+3% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $1.03B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $953.0M+16% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $820.6M−4% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $858.8M | SEC ↗ |